Ahmad A. Aref, MD
Dr. Aref performs trabeculectomy and glaucoma drainage implant surgery for advanced glaucomatous disease, as well as microinvasive glaucoma surgery for patients with mild to moderate disease, using the latest surgical innovations. He specializes in complex cataract surgery and is certified in the use of a femtosecond laser system for laser-assisted cataract extraction. He is researching the use of fish oil capsules in the treatment of dry eye, which is a frequent side-effect of medications used to treat glaucoma. Funding for the research is provided by the American Glaucoma Society. Dr. Aref has authored more than 20 peer-reviewed articles and book chapters and also is a reviewer for several peer-reviewed journals.
Dr. Aref is board-certified by The American Board of Ophthalmology as well as The Royal College of Physicians and Surgeons of Canada. He joined the Illinois Eye and Ear Infirmary in 2011.
Dimitri Azar, MD, MBA
Dr. Azar is an internationally recognized ophthalmic surgeon who brings experience in administration, research, education and clinical practice to his position as Dean of the College of Medicine at University of Illinois.
He joined the faculty in 2006 as Head of the Department of Ophthalmology & Visual Sciences. Previously he was a tenured Professor of Ophthalmology at Harvard Medical School, Director of the Cornea Service at Massachusetts Eye and Ear Infirmary, Senior Scientist at Schepens Eye Institute and a faculty member at Johns Hopkins School of Medicine. He earned an executive MBA from University of Chicago. Dr. Azar is board certified in ophthalmology.
He is a leader in basic science and clinically related vision research, making significant contributions to the treatment of corneal diseases and to advances in refractive surgery through mathematical analyses and applications of advanced optics. His basic science research on matrix metalloproteinases in corneal wound healing and angiogenesis has been continually funded by the National Eye Institute R01 award since 1993.
Dr. Azar is the author of more than 400 scientific articles and book chapters. He is the editor of 14 books in ophthalmology and holds 15 patents. He has been named one of The Best Doctors in America or recognized among Castle Connolly’s Regional Top Doctors in America annually since 1994. He serves as a trustee for the Chicago Ophthalmological Society and for the Association of Research and Vision in Ophthalmology. Dr. Azar has received multiple leadership awards, including the 2009 Lans Distinguished Award and the University of Illinois at Chicago Scholar Award.
Nathalie Azar, MD
Dr. Azar is recognized as an outstanding surgeon who is highly regarded by her peers in ophthalmology. She is known for her expertise in amblyopia and eye movement disorders, Graves’ disease and paralytic and restrictive strabismus. She frequently lectures at national meetings, including the American Association for Pediatric Ophthalmology and Strabismus, and organizes the pediatric and adult strabismus course for the Lancaster Course in Ophthalmology. Dr. Azar came to the Illinois Eye and Ear Infirmary in 2006 from Harvard’s Massachusetts Eye and Ear Infirmary, where she also directed the Pediatric Ophthalmology and Adult Strabismus Service. She is a board-certified ophthalmologist.
R.V. Paul Chan, MD, FACS
Dr. Chan’s clinical focus is medical and surgical vitreoretinal disease with a particular interest in the diagnosis and management of pediatric retinal disease and retinopathy of prematurity (ROP). His research interests include investigations into new methods to diagnose and manage pediatric retinal disease and ROP including the use of novel imaging techniques to improve our understanding of these conditions; identification of risk factors and genetic markers for pediatric retinal disease; telemedicine, computer facilitated image analysis, and tele-education to improve the quality of care for pediatric retinal conditions and ROP in the United States and internationally. Dr. Chan is board certified in Ophthalmology and a Fellow of the American College of Surgeons. He is listed with Castle Connolly's Top Doctors. Dr. Chan sees patients at the Illinois Eye and Ear Infirmary and the Millennium Park Eye Center.
Jose de la Cruz, MD
Dr. de la Cruz specializes in refractive surgery, advanced technology intraocular lens implantation, laser-assisted cataract and cornea surgery and complex corneal transplant surgery. He is certified in the use of the LenSx Femtosecond Laser for cataract surgery. Dr. de la Cruz has been focusing his skills in the field of ophthalmology for more than a decade. He was the chief resident of ophthalmology at the New York Eye and Ear Infirmary, and trained at Harvard Medical School in the subspecialty of cornea and refractive surgery (LASIK); both among the top ophthalmology institutions in the United States. Later, he came to the University of Illinois Eye and Ear Infirmary in Chicago where he completed his advanced refractive surgery clinical fellowship. As a trusted authority in the field, Dr. de la Cruz has co-authored several papers and book chapters comprising topics such as keratoprosthesis surgery (KPro), refractive surgery in presbyopic age group, infections in refractive surgery and of outcomes of laser assisted cataract surgery. At the Illinois Eye and Ear Infirmary, Dr. de la Cruz developed the k-pro program, considered the top artificial cornea service in the Midwest. He has been selected by his peers as one of The Best Doctors in America each year since 2009. He joined the Illinois Eye and Ear Infirmary faculty in 2007.
Ann-Marie Lobo, MD
Dr. Lobo’s clinical and research efforts are focused on the diagnosis and treatment of patients with ocular inflammatory and infectious diseases, including anterior, intermediate and posterior uveitis and scleritis. Her clinical interests include diagnostic testing in infectious uveitis, pediatric uveitis, and novel treatments for ocular inflammatory disease. Dr. Lobo has served as the principal investigator for several multi-center international clinical trials involving the use of novel therapies for the treatment of non-infectious uveitis. Her research interests include factors related to the development and severity of infectious uveitis, the morbidity of childhood uveitis, and the use of biologic response modifier therapies in the treatment of uveitis.
Dr. Lobo completed her residency in Ophthalmology and fellowship in Ocular Immunology and Uveitis in the Harvard Medical School Department of Ophthalmology, Massachusetts Eye and Ear Infirmary. She was on the full-time faculty in the Uveitis Service at Harvard Medical School from 2010-2015. She joined the Illinois Eye and Ear Infirmary faculty in September 2015. Dr. Lobo sees patients at the Illinois Eye and Ear Infirmary and the Millennium Park Eye Center.
Timothy McMahon, OD, FAAO
Dr. McMahon’s principal research interests are the pathobiology, genetics and clinical management of keratoconus, a degenerative disease of the cornea. His multi-center clinical trials are supported by numerous grants from the National Eye Institute, including the Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Corneal Topography Reading Center. Dr. McMahon is a member of the Board of Directors of the American Academy of Optometry and is a Diplomate in the Section on Cornea, Contact Lenses and Refractive Technologies. Dr. McMahon serves on the editorial board for the journals Cornea and Eye & Contact Lens. The National Academies of Practice, an organization of outstanding health care practitioners dedicated to quality healthcare for all, named him a Distinguished Clinical Fellow. Dr. McMahon sees patients at the Illinois Eye and Ear Infirmary and the Millennium Park Eye Center.
William Mieler, MD
Dr. Mieler is an expert in treating diseases of the macula, retina and vitreous. His primary research interests are ocular pharmacology, exploring drug delivery to the posterior segment of the eye, uptake and potential toxicity of topical, periocular and systemic medications, intraocular tumors and response to therapy and ocular imaging. He also participates in numerous national clinical trials for the treatment of age-related macular degeneration, diabetic macular edema, venous occlusive diseases and vitreoretinal interface disorders. Dr. Mieler received the Life Achievement Honor Award from the American Board of Ophthalmology (AAO) and served as its director, vice-chair and chair. He is a past president of the Macula Society, which awarded the 2013 J. Donald Gass Medal to him for his outstanding contributions to the study of macular diseases. He has published 330 peer-reviewed articles, 70 book chapters and edited or co-edited six ophthalmic textbooks. He has delivered 19 named lectures, served on editorial boards for three ophthalmic journals and is a reviewer for 22 additional journals. He is Retina Section Trustee and President-Elect of the Association for Research in Vision and Ophthalmology (ARVO). Dr. Mieler also served on several committees of the American Board of Medical Specialties. He joined the Illinois Eye and Ear Infirmary in 2008. Dr. Mieler is board certified in ophthalmology.
Heather Moss MD, PhD
Dr. Moss focuses on neuro-ophthalmologic conditions, including optic neuropathies, cerebral causes of vision loss, cranial nerve palsies, ocular myasthenia gravis and other eye movement disorders. Dr. Moss is conducting clinical trials for the diagnosis and treatment of common neuro-ophthalmic conditions including non-arteritic anterior ischemic optic neuropathy (NAION) and papilledema. Her interests are vision manifestations of neurological diseases and studying visual impairment in patients with amyotrophic lateral sclerosis to help define subtypes of this neurodegenerative disorder. She joined the Illinois Eye and Ear Infirmary in 2010 and is board certified in neurology.
Mark Rosenblatt, MD, PhD, MBA
Dr. Rosenblatt is a corneal surgeon and a highly accomplished physician-scientist, with a National Institutes of Health sponsored research program exploring mechanisms to regenerate corneal nerves following corneal injury. His primary focus is innovation and the translation of basic discoveries in the laboratory into relevant therapies for patients.
Prior to joining the faculty as Department Head in October, 2014, Dr. Rosenblatt was Director of the Margaret M. Dyson Vision Research Institute and Vice Chair of Ophthalmology at Weill Cornell Medical College.
Dr. Rosenblatt has made significant contributions to our understanding of corneal nerve regeneration, as well as the establishment of innovative models for investigating corneal nerves. At Weill Cornell Medical College, Dr. Rosenblatt expanded his research program to not only include regenerative issues related to corneal nerves, but also to regeneration of the ocular surface. He is currently exploring novel ways to promote trans-differentiation of skin stem cells into corneal epithelial stem cells for the treatment of corneal epithelial stem cell deficiency. In support of these regenerative medicine projects, Dr. Rosenblatt has received funding from the National Institutes of Health, the New York Stem Cell Initiative, the Tri-Institutional Institute for Stem Cell Biology, and SBIR funding from the Department of Defense and the National Science Foundation. Dr. Rosenblatt has published numerous papers in peer-reviewed journals, book chapters and presented at national and international academic meetings. He is Cornea Section Editor for the Clinical and Experimental Ophthalmology Journal and serves on the Editorial Board of Investigative Ophthalmology and Vision Science.
Dr. Rosenblatt’s clinical practice focuses on laser vision correction surgery and the treatment of cataracts and corneal disease. He is board certified in ophthalmology.
Pete Setabutr, MD
Dr. Setabutr is a fellowship-trained, board-certified ophthalmologist specializing in cosmetic and reconstructive oculofacial surgery. He is one of only 500 surgeons worldwide to have completed an American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS) approved fellowship. He has lectured throughout the U.S. and has a strong interest in clinical research and teaching. His clinical research focuses on disease of the eyelids and orbit. He is exploring innovative procedures to guide surgeons in rejuvenating the eyelids. Dr. Setabutr joined the Illinois Eye and Ear Infirmary faculty in 2009.